Medication Guide for patients
- Includes Important Product Information for PRISTIQ
This document is in PDF (portable document format). PDF files require Adobe® Reader®; click here.

This document is in PDF (portable document format). PDF files require Adobe® Reader®; click here.
PRISTIQ® (desvenlafaxine) is approved for the treatment of major depressive disorder in adults.
Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, teens, and young adults. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. PRISTIQ is not approved for use in children under 18.